SOCS2 is a pleiotropic E3 ligase. Its deficiency is associated with gigantism and organismal lethality upon inflammatory challenge. However, mechanistic understanding of SOCS2 function is dismal due to our unawareness of its protein substrates. We performed a mass spectrometry based proteomic profiling upon SOCS2 depletion and yield quantitative data for ~4200 proteins. Through this screen we identify a novel target of SOCS2, the serine-threonine kinase NDR1. Over-expression of SOCS2 accelerates turnover, while its knockdown stabilizes, endogenous NDR1 protein. SOCS2 interacts with NDR1 and promotes its degradation through K48-linked ubiquitination. Functionally, over-expression of SOCS2 antagonizes NDR1-induced TNFα-stimulated NF-κB activity. Conversely, depletion of NDR1 rescues the effect of SOCS2-deficiency on TNFα-induced NF-κB transactivation. Using a SOCS2 −/− mice model of colitis we show that SOCS2-deficiency is pro-inflammatory and negatively correlates with NDR1 and nuclear p65 levels. Lastly, we provide evidence to suggest that NDR1 acts as an oncogene in prostate cancer. To the best of our knowledge, this is the first report of an identified E3 ligase for NDR1. These results might explain how SOCS2-deficiency leads to hyper-activation of NF-κB and downstream pathological implications and posits that SOCS2 induced degradation of NDR1 may act as a switch in restricting TNFα-NF-κB pathway.
Scientific RepoRts | 7:42800 | DOI: 10.1038/srep42800 of a number of proteins that could mediate the interplay between SOCS2 and NF-κ B. In this investigation, the relationship between SOCS2 and NDR1 and its consequence for NF-κ B activation is explored in detail.
Results
Quantitative proteomic screen of SOCS2 depleted cells identifies novel putative targets. We began our study by performing an unbiased proteomic screen to identify potential substrates of SOCS2. Physiological substrates of SOCS2 that are degraded in its presence are expected to accumulate when SOCS2 is depleted. We used an RNAi knock-down approach to avoid secondary effects of long-term SOCS2 depletion. Expression of SOCS2 was quantitated using immunoblotting (IB) (Fig. 1A) . The overall effect on cell proliferation was measured by FACS ( Fig. 1B) , showing minor effects in the cell cycle upon SOCS2 depletion in mouse embryonic fibroblasts (MEFs). We characterized the proteome of SOCS2 wild-type (SOCS2 WT ) and knock-down (SOCS2 KD ) MEFs using nanoLC-MS/MS (nanoscale liquid chromatography coupled to tandem mass spectrometry) based proteomics (Fig. 1C ). Three independent experiments were carried out using two different siRNAs against SOCS2, resulting in biological triplicates of essentially two biological groups. MS data of the biological triplicates from both groups were combined and analyzed by using a combination of MaxQuant and Perseus (see Methods). Relative label-free quantification (LFQ) was fairly reproducible between the triplicates, while some variation was observed across the different groups as depicted by principle component analysis (Fig. 1D ). Overall, using this approach we detected ~5000 proteins and document quantitative data for > 4200 proteins upon SOCS2 depletion (Fig. 1E ). Expression of most proteins (94.6%) were unaltered and only a very small subset of proteins (5.4%), which satisfied the criteria of a fold-change (± ) of ≥ 1.5 and P-value < 0.05, showed differences between SOCS2 WT and SOCS2 KD MEFs ( Table 1 and Table S1 ). No expression of SOCS2 or its previously identified target, the GHR (growth hormone receptor), was detected most likely due to their low abundances 15 .
Both endogenous and exogenously expressed NDR1 is destabilized by SOCS2. Bioinformatics analysis and text mining of significantly upregulated proteins in our dataset identified a handful of proteins previously associated with the regulation of NF-κ B activity (See Fig. 1E ). Literature review indicated that FER, GOLPH3 and STK38 upregulates NF-κ B activity [16] [17] [18] . Given the recently published link between NDR1(STK38) Continued and TNFα -induced NF-κ B activation, we focussed our attention on NDR1. To investigate the possibility that SOCS2 regulates NDR1, we first used immunoblotting (IB) to verify that depletion of SOCS2 by siRNAs indeed increased the cellular levels of endogenous NDR1 protein under resting conditions ( Fig. 2A ) and when de novo protein synthesis has been blocked using cycloheximide ( Fig. 2B ). Over-expressed FLAG SOCS2 could decrease endogenous NDR1 protein but not mRNA ( Fig. 2C-E ). Furthermore, FLAG SOCS2 could destabilize exogenously expressed Myc NDR1 in MEFs in a dose-dependent manner ( Fig. 2F ) and in a panel of different cell lines ( Fig. 2G ).
We also observed that FLAG SOCS2 WT but not FLAG SOCS2 ΔSB (deletion of SOCS box which is required for interaction with ElonginB/C and Cullin5 complex) mutants could decrease levels of endogenous NDR1 protein ( Fig. 2H ), suggesting that the SOCS-box domain is required for SOCS2 to regulate NDR1 abundance, likely mediated through the Cullin5 E3 ligase. Consistently, depletion of Cullin5 increased NDR1 protein levels ( Fig. 2I ).
Over-expressed Myc NDR1 did not have any detectable effects on the total protein levels of exogenous FLAG SOCS2 in MEFs ( Fig. 2H ). We also observed that the destabilizing effect of FLAG SOCS2 on Myc NDR1 is further enhanced after treatment with TNFα ( Fig. 2J ). It is known that the interaction of SOCS2 with its target is mediated through phosphorylated tyrosine (Y) residue(s) on the substrate. Substitution of several of the Y residues on NDR1 with high probability of phosphorylation (source: PhosphoSitePlus database), could not abolish the ability of SOCS2 to degrade NDR1 ( Figure S1 ), suggesting requirement of either multiple phospho-Y sites or Y residues other than the mutated ones. Collectively, these data demonstrate that NDR1 protein is regulated by SOCS2.
SOCS2 interacts with NDR1 leading to its polyubiquitination. Consistent with a role of SOCS2
in regulating NDR1 stability, over-expressed Myc NDR1 was detected in exogenously expressed FLAG SOCS2 ΔSB pull-down complexes and vice versa in HEK293T cells (Fig. 3A,B ). We used a SOCS-box deleted form of SOCS2 Table 1 . Upregulated proteins identified in the proteomics screen which satisfied the criteria of a foldchange of >1.5 and P-value < 0.05.
for the pull-down assays to prevent SOCS2-induced degradation of NDR1 and to avoid Cullin5-interacting proteins in the immunoprecipitation. This interaction was confirmed in MEFs under endogenous conditions ( Fig. 3C ). We previously observed that FLAG SOCS2 over-expression could decrease levels of endogenous NDR1. This effect of SOCS2 on NDR1 is reversed by MG132 (26 S proteasome inhibitor) treatment ( Fig. 3D ), indicating that SOCS2 triggered reduction in NDR1 requires activity of the 26 S proteasome. Indeed, we observed a quantitative increase of high molecular weight polyubiquitinated forms of Myc NDR1 upon FLAG SOCS2 WT over-expression ( Fig. 3E ) but not FLAG SOCS2 ΔSB over-expression ( Fig. 3F ) and these polyubiquitination was through K48-linkage ( Fig. 3G ). On the basis of above data, we propose that SOCS2 destabilizes NDR1 by promoting ubiquitination and its subsequent degradation by the 26 S proteasome.
SOCS2 deficiency stimulates NF-κB activation in response to TNFα. Because NDR1 potentiates NF-κ B signaling in the presence of TNFα ligand 18 , we wished to evaluate the effect of SOCS2 on this aspect of NDR1 function due to its potential implications for clarifying the mechanisms behind SOCS2 anti-inflammatory actions, as mentioned above. However, before delving on to the functional implications of SOCS2 perturbations on NDR1-potentiated NF-κ B signaling, we first asked what is the role of SOCS2 in TNFα -induced NF-κ B activation in MEFs under our experimental conditions. IB analysis of cytoplasmic and nuclear extracts showed that MEFs depleted of SOCS2 (SOCS2 KD ) had significantly higher nuclear p65 levels, as compared to wild-type (SOCS2 WT ) cells, after stimulation with TNFα ( Fig. 4A ). We obtained similar results using high-content quantitative imaging (HCQI) ( Figure S2A , B and Fig. 4B ,C) which allowed detection of nuclear p65 quantitatively in situ 19, 20 . Consistently, SOCS2 KD cells were hyper-responsive to TNFα ligand with respect to NF-κ B activity as determined by luciferase reporter assay ( Fig. 4D) and changes in mRNA levels of the NF-κ B target gene IL-6 ( Figure S2C and Fig. 4E ). We also observed that SOCS2 depletion resulted in changes in proteins secreted by TNFα -stimulated MEFs that promoted NF-κ B transactivation in wild-type cells (i.e., in a paracrine manner) ( Fig. 4F-I) . We contextualize our in vitro data in an in vivo setting by using the murine DSS (dextran sodium sulphate) model of ulcerative colitis (UC) 21 where TNFα is a major driving factor 22 . DSS-administered induction of UC has not been previously reported in SOCS2 knock-out (SOCS2 −/− ) mice. We found that in comparison to wild type mice, colonic tissue from SOCS2 −/− mice showed exacerbated inflammation upon DSS treatment ( Fig. 4J,K) . Consistently, we observed much stronger nuclear staining for p65 in SOCS2 −/− , as compared to SOCS2 WT , mice after DSS administration (Fig. 4L ) which was reflected in higher transcript levels of known NF-κ B target genes, iNOS and IL-1β ( Fig. 4M) . As a whole, our observations indicate that SOCS2 depletion facilitates NF-κ B signaling. does this correlate to NDR1. In MEFs, transient over-expression of NDR1 amplifies TNFα -induced NF-κ B signaling ( Figure S3A-C) . Consistently, depletion of NDR1 causes reduction of NF-κ B dependent luciferase activity in both presence and absence of external TNFα stimulation, although the effect is more pronounced in presence of TNFα (Fig. 5A,B ). Using HCQI we show that over-expression of NDR1 and down-regulation of SOCS2 had a combined additive effect on TNFα -induced nuclear translocation of p65 ( Fig. 5C ). Further, depletion of SOCS2 increased luciferase readout over TNFα stimulation alone, while knock-down of either NDR1 or double knock-down of both NDR1 and SOCS2 reduced NF-κ B luciferase reporter activity below that of TNFα treatment (Fig. 5D ) suggesting NDR1 to be downstream of SOCS2. Conversely, SOCS2 over-expression should diminish the strengthened transactivation potential of NF-κ B in response to TNFα . To test this, we measured mRNA levels of well-known NF-κ B target genes (MCP-1, NFKB1A and Arginase-1) using quantitative real-time PCR (qPCR) analysis upon NDR1 and SOCS2 overexpression either alone or in combination in MEFs (Fig. 5E ). We observed that overexpression of SOCS2 alone stimulated the transcription of these genes. This is not unexpected given these genes may not be exclusively regulated by NF-κ B under resting conditions and apparently depend on unidentified factors that are influenced by SOCS2. Nevertheless, NDR1 had an augmenting effect on the transcription of all the genes tested, and importantly, in all instances SOCS2 truncated this effect (Fig. 5E ). We also provide a correlative support to our in vitro observations by showing that inflamed SOCS2 −/− colonic tissues isolated from DSS-treated mice had elevated total levels of NDR1 protein as compared to similarly treated wild-type mice (Fig. 5F,G) . As a whole, our observations potentially point towards an explanation for the effects of SOCS2 on NF-κ B activity and the hyper-inflammatory phenotype of SOCS2 deficient animals.
NDR1-mediated

NDR1 amplifies the aggressive behaviour of PC3 cells.
We previously observed that SOCS2 acts as a tumour suppressor in advanced castration-resistant prostate cancer. Bone metastases clinical samples of human patients exhibit reduced levels of SOCS2 in comparison with localized or hormone naive untreated adenocarcinomas 23 . A majority of these advanced tumors are known to have an elevated dependency on NF-κ B signaling for their survival 24 . Since SOCS2 deficiency could lead to an elevated NDR1 levels, we wanted to see how an "over-expressing" NDR1 protein itself would impinge on the tumorigenic properties of cancer cells. As per our knowledge this has not been tested before. For this we selected PC3 prostate cancer cells, partly because of their "addiction" to NF-κ B signaling 25, 26 . To determine whether NDR1 over-expression alters the anchorage-independent growth of PC3 cells we performed soft-agar colony-formation assay and observed a marked difference in the number of colony-forming units. NDR1-overexpression in PC3 cells (PC3-NDR1) potentiated sphere-forming capacity by ~2.9-fold as compared to cells transfected with empty vector (PC3-EV) (Fig. 6A ). However, PC3-NDR1 cells did not appear to have a significantly altered cell cycle profile in comparison to PC3-EV cells as measured using FACS analysis (Fig. 6B ). PC3-NDR1 cells also had relatively higher invasive potential through Matrigel chamber (Fig. 6C) . We next performed 2-dimensional wound-healing assay to test the migratory behaviour of these cells and found that PC3-NDR1 cells repopulated the cell-free clearing produced by the scratch faster than PC3-EV cells, indicating an increased migration rate. Importantly, inclusion of the NF-κ B inhibitor parthenolide abrogated wound-healing capacity of both PC3-EV and PC3-NDR1 cells (Fig. 6D) highlighting the crucial role played by NF-κ B in these cells. Taken together, these data demonstrate that NDR1 might act as a driver of oncogenic growth in NF-κ B addicted tumors, although further research is needed to fully justify this claim.
Discussion
As mentioned above, the intracellular mechanisms by which anti-inflammatory actions are exerted by SOCS2 are poorly understood. This problem is related with our scarce knowledge of its cellular targets. To shed light on this aspect, we performed an unbiased nanoLC-MS/MS based quantification of cellular proteins in MEFs after transient knock-down of SOCS2 and enlisted 136 upregulated proteins. Of note, based on this experimental design we cannot rule out the contribution of secondary effects to changes in protein concentration, and the numbers of direct targets of SOCS2 are likely to be lower. Thus, additional research is needed to establish whether and how proteins identified in this analysis as putative SOCS2 targets are indeed ubiquitinated by SOCS2 and how they contribute to its cellular functions, including inflammation. Nonetheless, as it stands, this is the first report of a global quantitative proteomics effort specifically directed towards identification of SOCS2 regulated proteins.
Our proteomic data revealed NDR1 as a potential target for SOCS2 ubiquitin ligase activity. NDR1 (or STK38) is a serine-threonine kinase. It belongs to the LATS/NDR family and controls many critical processes including centrosome duplication 27 , apoptosis and proliferation 28 , chromosome alignment 29 . It regulates signaling pathways such as MEKK1/2 30 , TGFβ 31 , Hippo 32 and TLR9 33 . Recently, NDR1 was shown to potentiate NF-κ B signaling in the presence of TNFα ligand in HEK293T and HeLa cells 18 . Evidences indicate NDR1 protein is highly regulated through phosphorylation 32 and the ubiquitin proteasome system 31 . Several kinases, including MST1 34 and GSK3β 35 are known to regulated NDR1 activity under various contexts. However, no physiological E3 ligase had yet been reported for NDR1.
Using immunoprecipitation, we show that SOCS2 and NDR1 exist in the same complex. NDR1 was found to be a substrate of wild-type SOCS2 but not a SOCS-box truncated form i.e., SOCS2-Δ SB. SOCS2 acts as the substrate recognition module of Cullin5/Rbx2 E3 ligase "holoenzyme" and depends on its C-terminus SOCS box to interact with the complex, suggesting the involvement of Cullin5 E3 ligase. Consistently, knock-down of Cullin5 using RNAi stabilized NDR1 protein. Overexpression of SOCS2 increases polyubiquitination of NDR1 subsequently targeting it to 26S proteasomes as indicated by an increased ubiquitin-NDR1 conjugates in presence of MG132. We also provide data to support that SOCS2 ubiquitination of NDR1 is mediated mainly by K48-Ub-specific linkages that are mostly associated with proteolysis. Conversely, our data showing stabilization of NDR1 upon SOCS2 depletion indicates a constitutive ligase-substrate relation between them.
Considering some of the latest evidences, it appears that SOCS2 probably orchestrates multiple regulatory nodes in the inflammatory pathway 8, [36] [37] [38] . We observed that over-expression of NDR1 alone had a two-fold enhancing effect on NF-κ B transactivation, as judged by qPCR of well-known NF-κ B target genes. Not surprisingly, the overall impact was much stronger when the cells were induced with TNFα but the fold change was still ~2.0 fold. Therefore, our report agrees with Shi et al., that NDR1 potentiates TNFα induced NF-κ B signaling, however, the mechanism behind this effect is yet to be uncovered. Here we report SOCS2 induced destabilization of NDR1. SOCS2 can constitutively degrade NDR1 without an activating stimulus (other than provided by standard cell culture conditions), although interestingly, a TNFα stimulus seem to make NDR1 a better target of SOCS2. Based on our proteomics observations, we believe that NDR1 protein is relatively more abundant than SOCS2 because we repeatedly detected NDR1 by mass spectrometry analysis but not SOCS2. This might mean that manipulating SOCS2 levels may serve a switch for controlling TNFα -NF-κ B signaling mediated through NDR1.
We offered evidence that SOCS2 regulation of NDR1 may be relevant for inflammation and carcinogenesis. Our observations showing elevated tumorigenic properties of PC3 cells in response to NDR1 over-expression raises interesting questions and begs further research into the carcinogenic role of NDR1. Given the role of NF-κ B signaling in multiple human malignancies, our study raises the potential for SOCS2-NDR1-NF-κ B axis as a target for drug discovery in inflammation and cancer biology.
Overall, the data presented in this study (1) provides evidence for an inhibitory role of SOCS2 in TNFα induced NF-κ B activation, (2) identifies NDR1 as a novel substrate of SOCS2, and (3) demonstrates that SOCS2 and TNFα induced NF-κ B signaling are linked through NDR1. Through this study, we provide a mechanistic explanation for the well-acknowledged hyper-inflammatory phenotype of SOCS2-deficient animals (Fig. 7 ).
Materials and Methods
Cell Culture, transfection and drug treatments. Cells were cultured using standard protocols. Expression plasmids and siRNA. Human SOCS2 gene (NM_003877) was PCR amplified from total HEK293T cDNA. Full-length SOCS2 and SOCS2 ΔSB deletion mutant (amino acids 1-145) were cloned into pcDNA 4/TO vector with an N-terminal FLAG epitope to generate FLAG SOCS2 WT and FLAG SOCS2 ΔSB . pcDNA4/TO-HA-Strep-ubiquitin WT, K48-only and K48R were a kind gift from Niels Mailand (University of Copenhagen). Myc-tagged NDR1 was obtained from Addgene (Plasmid #37023, a kind gift from Yutaka Hata). Point mutations of Myc-NDR1 were created using the site-directed mutagenesis kit (Agilent Technologies) as per manufacturer's instructions. All plasmids were verified by sequencing. Sequences of primers used can be provided upon request. All siRNAs were purchased from Qiagen and used at a final concentration of 80 nM. Sequences are given in Table S2 . Preparation of conditioned medium. Cells were starved in serum-free media for 16 hours before being pulsed with TNFα (10 ng/ml) for 1 hour after which residual TNFα was washed twice using PBS. Serum-free media was again replenished and cells were inubated for another 4 hours. CM were collected, clarified by centrifugation and passed through sterile 0.22 μ m sterile filter. CM were used freshly.
Co-immunoprecipitation (co-IP) and immunoblot (IB) analyses. For co-IP experiments, cells were
lysed on ice using IP buffer (50 mM HEPES, pH 7.2, 250 mM NaCl, 10% glycerol, 1% Nonidet P-40, 1.0 mM EDTA, 10 mM phenylmethanesulfonylfluoride (PMSF), 50 mM sodium fluoride, 0.2 mM sodium orthovanadate (Na 3 VO 4 ), 25 mM β -glycerophosphate and protease inhibitor cocktail from Roche). After pre-clearing with Protein A Sepharose beads (Amersham Biosciences), 2 mg of total protein was subjected to immunoprecipitation as described previously 39 . For western blotting, cells were lysed on ice using RIPA buffer (50mM Tris pH 7.4, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X 100, 10 mM phenylmethanesulfonylfluoride (PMSF), 50 mM sodium fluoride, 0.2 mM sodium orthovanadate (Na 3 VO 4 ), 25 mM β -glycerophosphate and protease inhibitor cocktail from Roche). The following antibodies were used: Santacruz Biotechnology -GAPDH, Myc (9E10), NDR1(STK38), Ubiquitin; Sigma -β -actin, HA, FLAG(M2); Abcam -SOCS2; Abnova -NDR1; Cell Signaling Technology -SOCS2, p65, FLAG. Pixel densitometric measurements of immunoblots was done using the ImageJ software (https://fiji.sc/). Orbitrap Q-Exactive MS/MS and proteomics data analysis. Lysates were prepared as described previously 40 . From each sample, 100 μ g of proteins were first digested with Lys-C (4 hours at 37 °C) followed by dilution of guanidine hydrochloride to < 2 M with 50 mM ammonium bicarbonate prior to the addition sequencing grade Trypsin (overnight at 37 °C). Enzyme activity was quenched by acidification of the samples with trifluoroacetic acid (TFA) and the peptide mixture was desalted and concentrated on a C 18 Stagetip before elution with 50% acetonitrile, 0.1% TFA. The eluate was concentrated in a SpeedVac at 60 °C and acidified with 5% ACN, 1% TFA before being analyzed using an EASY-nLC system (Proxeon) connected to a Q Exactive mass spectrometer (Thermo Fisher Scientific) through a nano-electrospray ion source. Peptides were separated in a 15-cm analytical column (75 μ m inner diameter) in-house packed with 1.9 μ m diameter reversed-phase C 18 beads (ReproSil-Pur AQ, Dr. Maisch) with an increasing gradient from 5 to 30% buffer B (80% acetonitrile, 0.1% formic acid) in 120 minutes at a flow rate of 250 nl/min followed by an increase to 40% B in 15 minutes where it was briefly held prior to 80% B for 5 minutes followed by column re-equilibration at 5% B. The Q-Exactive was operated in data-dependent acquisition mode using the "sensitive scanning method" 41 . Raw MS files from the Q-Exactive were analyzed by MaxQuant 1.4.1.1 with the Andromeda search engine 42 . Tandem mass spectrometry spectra were searched against the decoy International Protein Index-Mus musculus database version 3.62 containing both forward and reverse protein sequences. The search included variable modifications of methionine oxidation and N-terminal acetylation, and fixed modification of cysteine carbamidomethylation. Peptides of minimum seven amino acids and maximum of two missed cleavages were allowed for the analysis. False discovery rate of 1% was used for the identification of peptides and proteins. Bioinformatics analysis of the data were mainly performed using the Perseus computational platform 43 Luciferase assays. Luciferase activity of NF-κ B reporter was determined luminometrically using the Dual-Glo luciferase assay system (Promega). MEFs (10 6 ) were transiently transfected with pGL4.74-hRluc/TK (10 ng) and pGL4.10.NF-κ B reporter (100 ng) vectors along with the indicated constructs. Luciferase activity of cell extracts in passive lysis buffer was determined luminometrically using the Varioskan multiplate reader (Thermo Fisher Scientific).
Microscopy. Protocol has been described before 39 . For High-Content Quantitative Imaging (HCQI), photographs were captured on Olympus IX-81 motorized fluorescence microscope equipped with an Olympus UPLSAPO 20x/0.75 NA objective. Automated and unbiased image analysis was carried out with the ScanR acquisition software. For confocal fluorescence microscopy, images were captured on a Zeiss LSM 700 imaging system.
Quantitative real-time PCR (qPCR).
Total RNA was extracted using the RNeasy kit (Qiagen). For each sample, 1 μ g of RNA was converted to cDNA using iScript cDNA synthesis kit (Biorad), diluted 1:5 with water and subsequently used for qPCR analysis using Brilliant III ultra-fast SYBR ® green (Agilent Technologies) on a 7500
Fast Real-Time PCR system (Applied Biosystems). In all experiments, 18S rRNA served as the internal control (normalization) and calibrator controls were chosen appropriately. Sequences of the primers used are given in Table S3 .
Immunohistochemistry. Tissue sections were deparaffinized in xylene and rehydrated through graded ethanol. For antigen retrieval slides were steamed for 30 minutes in EnVision FLEX Target Retrieval Solution (pH 6.1) (Dako). Antibody incubations were done overnight at 4 °C in Shandon coverplates (Thermo Fisher Scientific). For detection, HiDef HRP polymer system (Sigma-Aldrich) was used followed by incubation with DAB + chromogen (DAKO) according to manufacturer's instructions. Slides were counterstained with Mayers hematoxylin for 1 minute. All immunohistochemical procedures were undertaken in one batch. The antibody for p65 was from Cell Signaling Technology.
Laboratory Animals and Experimental Colitis.
Mice were housed under standard conditions [12:12-hour light-dark cycles, 22 ± 2 °C and about 60% humidity] with ad libitum feeding. Male SOCS2 knockout (SOCS2− /− ) and SOCS2-wild type (SOCS2+ /+ ) littermate mice between 12-16 weeks' old were used and they were allowed to acclimate to these conditions for a week before the start of the experiment. Colonic inflammation was induced by oral administration of 3% (w/v) Dextran Sodium Sulfate (DSS; T&D consulting, Uppsala, Sweden) dissolved in drinking water for 5 days and then switched to normal drinking water until day 20. Mice were sacrificed after euthanasia by total bleeding and cervical dislocation after anesthesia by isoflurane. Entire colons of DSS treated and untreated mice were dissected and contents flushed with ice-cold saline. The distal third of the colon was dissected into equal pieces for histological analysis and RNA & protein extractions. Following H + E staining, specimens were evaluated for histological colitis scoring by two independent pathologist using light microscopy. The scoring of histological changes in the colon was done according to Cooper et al. 44 , which include the assessment of Crypt loss, infiltration of neutrophil, lymphocytes and goblet cell depletion 45, 46 . Histological findings were given a score based on the severity of the colitis (Table S4) . Animal handling and all experimental protocols were performed in accordance with the relevant guidelines and regulations approved by the "Animal Ethics Committee" of Sultan Qaboos University, Oman.
Soft-agar colony formation assay. For soft-agar assays, 300 cells were suspended in RPMI containing 0.35% agar and layered on top of 1 ml of RPMI solidified with 1.0% agar in each 35-mm dish. After growing at 37 °C for 14 days, colonies were visualized and counted in three different microscopic fields.
Wound healing assay. The migratory behavior of PC3 cells were evaluated using the scratch (wound healing) assay. Briefly, equal number of cells were seeded on 6-well plates and allowed to reach confluency. Several scratches were made using a 200 μ l pipette tip spanning the well. Migration of cells was observed at premarked positions below the wells using an Olympus IX81 inverted microscope at 40X magnification.
Matrigel invasion assay.
Matrigel (60 μ l at 1:4 dilutions in RPMI medium) was coated on the top of Transwell filters (6.5-mm diameter, 8.0-μ m pore size, Costar, Corning, NY) for 4 h at 37 °C. Chemoattractant (10 ng/ml TNFα ) was added to bottom chambers of transwells and cells (50,000) were plated on Matrigel in RPMI and allowed to migrate overnight at 37 °C through Matrigel. Migrated cells were fixed in 4% paraformaldehyde in PBS for 15 minutes and permeabilized with 0.2% Triton -X100 in PBS for 10 minutes. Cells migrated to the lower chamber were stained with 0.5 μ g/ml DAPI in PBS. Fluorescence pictures were acquired using an Olympus IX81 inverted microscope at 40X magnification from three random fields and nuclei were counted using ImageJ.
Statistical analysis. All statistical calculations were done using the GraphPad QuickCalcs software.
Student's t-test (unpaired) was used. A P value of < 0.05 was taken as significant and < 0.005 was considered extremely significant. For proteomics experiments, P values were calculated using the inbuilt statistical functions of Perseus platform.
